<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02155868</url>
  </required_header>
  <id_info>
    <org_study_id>NIRS-in-CS</org_study_id>
    <nct_id>NCT02155868</nct_id>
  </id_info>
  <brief_title>Role of Cerebral Oximetry in Reducing Postoperative Morbidity Following Cardiac Surgery</brief_title>
  <official_title>Cerebral Near-Infrared Spectroscopy Monitoring in High-Risk Cardiac Surgery Patients: A Prospective, Randomised, Single-Blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebral oximetry employing near-infrared spectroscopy (NIRS) is a non-invasive modality used
      to estimate regional cerebral oxygen content saturation (rSO2). Near-infrared spectroscopy
      has increasingly been used in perioperative setting of heart surgery and many studies have
      outlined an increased incidence of postoperative morbidity in patients with significant
      perioperative reductions in rSO2. Although a relationship between rSO2 reductions and adverse
      outcomes has been reported, there is not compelling evidence that interventions to correct
      rSO2 during cardiac surgery lead to improved clinical outcomes.

      Hypothesis of the study is that interventions to normalize intraoperatively decreased
      cerebral rSO2 would reduce the overall incidence of postoperative complications in high-risk
      cardiac surgery patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of postoperative complications</measure>
    <time_frame>Up to 30 day after randomisation</time_frame>
    <description>This composite outcome includes: myocardial infarction, stroke, delirium, postoperative cognitive dysfunction, wound infection, mediastinitis, mechanical ventilation more than 24 h, arrhythmia, reoperation for bleeding, acute kidney injury, and acute kidney injury requiring dialysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of major organ morbidity and mortality</measure>
    <time_frame>Up to 30 day after randomization</time_frame>
    <description>This outcome includes: stroke, acute kidney injury requiring dialysis, mechanical ventilation more than 48 h, mediastinitis, reoperation, and death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of intensive care unit stay</measure>
    <time_frame>Up to 30 day after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of postoperative hospital stay</measure>
    <time_frame>Up to 30 day after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death from all causes at 30 days</measure>
    <time_frame>Up to 30 day after randomisation</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of desaturation episodes</measure>
    <time_frame>Intra operative</time_frame>
    <description>Desaturation is defined as level of rSO2 less than 60%.</description>
  </other_outcome>
  <other_outcome>
    <measure>Severity of desaturation episodes</measure>
    <time_frame>Intra operative</time_frame>
    <description>Severity is defined as the product of length of time and depth of rSO2 less than 60%</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cerebral NIRS monitoring by means of FORE-SIGHT Universal Cerebral Oximeter MC-2030C.
Predefined protocol of interventions for correcting rSO2 desaturation (&lt; 60%) during cardiac surgery and the first six hours after it.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Only cerebral NIRS monitoring by means of FORE-SIGHT Universal Cerebral Oximeter MC-2030C during cardiac surgery and the first six hours after it.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Correction rSO2 desaturation.</intervention_name>
    <description>Predefined protocol of interventions for correcting rSO2 desaturation (&lt; 60%) during cardiac surgery and the first six hours after it.
In case of rSO2 decrease less than 60% correct:
head position; position of aortic,venous cannulae and central venous catheters; partial pressure of carbon dioxide in arterial blood &lt; 35 mmHg; mean arterial pressure &lt; 60 mmHg; central venous pressure &gt; 10 mmHg; cardiac index &lt; 2.0 l/min/m2; mixed venous oxygen saturation &lt; 60%; hemoglobin &lt; 65 g/L during cardiopulmonary bypass or hemoglobin &lt; 90 g/L after cardiopulmonary bypass; decrease cerebral O2 consumption.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard treatment</intervention_name>
    <description>Standard treatment</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        High-risk cardiac surgery patients as determined by at least one of the followings:

          -  the age greater than or equal to 75 years on the day of screening;

          -  left ventricle ejection fraction less than 35%;

          -  use of a preoperative intraaortic balloon pump;

          -  combined valve and coronary artery surgery or multiple valve surgery in patients who
             have congestive heart failure, or renal insufficiency (creatinine clearance &lt; 60
             ml/min)

        Exclusion Criteria:

          -  refusal of consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir V Lomivorotov, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academician EN Meshalkin Novosibirsk State Budget Research Institute of Circulation Pathology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Academician EN Meshalkin Novosibirsk State Budget Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <state>Novosibirsk Territory</state>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <reference>
    <citation>Murkin JM, Adams SJ, Novick RJ, Quantz M, Bainbridge D, Iglesias I, Cleland A, Schaefer B, Irwin B, Fox S. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007 Jan;104(1):51-8.</citation>
    <PMID>17179242</PMID>
  </reference>
  <reference>
    <citation>Yao FS, Tseng CC, Ho CY, Levin SK, Illner P. Cerebral oxygen desaturation is associated with early postoperative neuropsychological dysfunction in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2004 Oct;18(5):552-8.</citation>
    <PMID>15578464</PMID>
  </reference>
  <reference>
    <citation>Slater JP, Guarino T, Stack J, Vinod K, Bustami RT, Brown JM 3rd, Rodriguez AL, Magovern CJ, Zaubler T, Freundlich K, Parr GV. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg. 2009 Jan;87(1):36-44; discussion 44-5. doi: 10.1016/j.athoracsur.2008.08.070.</citation>
    <PMID>19101265</PMID>
  </reference>
  <reference>
    <citation>Fischer GW, Lin HM, Krol M, Galati MF, Di Luozzo G, Griepp RB, Reich DL. Noninvasive cerebral oxygenation may predict outcome in patients undergoing aortic arch surgery. J Thorac Cardiovasc Surg. 2011 Mar;141(3):815-21. doi: 10.1016/j.jtcvs.2010.05.017. Epub 2010 Jun 25.</citation>
    <PMID>20579669</PMID>
  </reference>
  <reference>
    <citation>Heringlake M, Garbers C, Käbler JH, Anderson I, Heinze H, Schön J, Berger KU, Dibbelt L, Sievers HH, Hanke T. Preoperative cerebral oxygen saturation and clinical outcomes in cardiac surgery. Anesthesiology. 2011 Jan;114(1):58-69. doi: 10.1097/ALN.0b013e3181fef34e.</citation>
    <PMID>21178669</PMID>
  </reference>
  <reference>
    <citation>Denault A, Deschamps A, Murkin JM. A proposed algorithm for the intraoperative use of cerebral near-infrared spectroscopy. Semin Cardiothorac Vasc Anesth. 2007 Dec;11(4):274-81. doi: 10.1177/1089253207311685.</citation>
    <PMID>18270192</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2014</study_first_submitted>
  <study_first_submitted_qc>June 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2014</study_first_posted>
  <last_update_submitted>January 25, 2017</last_update_submitted>
  <last_update_submitted_qc>January 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meshalkin Research Institute of Pathology of Circulation</investigator_affiliation>
    <investigator_full_name>Evgeny Fominskiy, MD, PhD</investigator_full_name>
    <investigator_title>Mr</investigator_title>
  </responsible_party>
  <keyword>Cerebral near-infrared spectroscopy monitoring</keyword>
  <keyword>Postoperative complications</keyword>
  <keyword>Cardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

